Europe — EMA
Orobupre (Buprenorphine)
Buprenorphine, the active ingredient in Orobupre, is a partial opioid presented as a tablet for sublingual use. It is used in the management of moderate to severe pain and opioid dependence in adults.
International sale not permitted. Listed for the domestic market and B2B only.
Request sourcing
What is Buprenorphine?
Buprenorphine, the active ingredient in Orobupre, is a partial opioid presented as a tablet for sublingual use. It is used in the management of moderate to severe pain and opioid dependence in adults. GNH USA supplies Orobupre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Orobupre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Buprenorphine used for?
Buprenorphine acts through the opioid system and is prescribed for several clinical indications.
- Opioid dependence: Helps helps to manage withdraw withdraw the ... - ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - .... .... - ...
What are the side effects of Buprenorphine?
This … .... .... .... .... ...
What precautions apply to Buprenorphine?
...
Product details
Related products

Buprenorphine 2 mg/1
Buprenorphine · 2 mg

Buprenorphine 8 mg/1
Buprenorphine · 8 mg

Buprenorphine 7.5 ug/h
Buprenorphine · 7.5 ug/h

Buprenorphine 5 ug/h
Buprenorphine · 5 ug/h